Literature DB >> 15968165

p53 Expression in pterygium by immunohistochemical analysis: a series report of 127 cases and review of the literature.

Yi-Yu Tsai1, Kong-Chao Chang, Chien-Lin Lin, Huei Lee, Fuu-Jen Tsai, Ya-Wen Cheng, Sung-Huei Tseng.   

Abstract

PURPOSE: To assess the p53 protein expression in pterygial tissue and to review all immunohistochemical studies on pterygium from Medline to evaluate the roles of age, gender, race, p53 antibody, cutoff levels of immunohistochemical analysis, parts of pterygium, p53 gene mutation spectrum, and primary or recurrent pterygium on the p53 staining results.
METHODS: Immunohistochemical staining was performed on 127 pterygial specimens and 18 normal conjunctival samples. All 8 immunohistochemical studies on p53 expression in pterygium from Medline were reviewed.
RESULTS: Among the 127 pterygial samples, there were 29 specimens (22.8%) positive for p53 expression. There was no significant difference between the p53-positive and p53-negative groups with respect to age or gender.
CONCLUSION: The positive rate of p53 staining in 8 immunohistochemical studies was 7.9%, 36.8%, 37.5%, 38.1%, 50%, 53.8%, 60%, and 100%, respectively. p53 protein antibody, cutoff level, race, and p53 gene mutational spectra all affect the results on the p53 staining. Different parts of pterygium and gender merit further evaluation in their role on p53 staining result.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15968165     DOI: 10.1097/01.ico.0000154404.86462.35

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  8 in total

1.  Survivin and p53 expression in primary and recurrent pterygium in Chinese patients.

Authors:  Li-Wei Zhang; Bai-Hua Chen; Xing-Hua Xi; Qian-Qian Han; Luo-Sheng Tang
Journal:  Int J Ophthalmol       Date:  2011-08-18       Impact factor: 1.779

2.  Chronic inflammatory cells and damaged limbal cells in pterygium.

Authors:  P Anguria; T Carmichael; S Ntuli; J Kitinya
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

Review 3.  Aberrant expression of genes and proteins in pterygium and their implications in the pathogenesis.

Authors:  Qing-Yang Feng; Zi-Xuan Hu; Xi-Ling Song; Hong-Wei Pan
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

Review 4.  The role of heredity in pterygium development.

Authors:  Peter Anguria; James Kitinya; Sam Ntuli; Trevor Carmichael
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

5.  Expression of WW domain-containing oxidoreductase WWOX in pterygium.

Authors:  Yi-Hsun Huang; Nan-Shan Chang; Sung-Huei Tseng
Journal:  Mol Vis       Date:  2015-06-25       Impact factor: 2.367

6.  Lymphatic microvessel density as a predictive marker for the recurrence time of pterygium: a three-year follow-up study.

Authors:  Haotian Lin; Lixia Luo; Shiqi Ling; Wan Chen; Zhaochuan Liu; Xiaojian Zhong; Changrui Wu; Weirong Chen; Yizhi Liu
Journal:  Mol Vis       Date:  2013-01-28       Impact factor: 2.367

7.  Role of concanavalin A lectin in recognition of pterygium remnant after surgical excision: preliminary results of a prospective study.

Authors:  Juan A Díaz-González; Miguel A Mayoral-Chávez; Paulina Leyva Bohórquez; Ma del Pilar Gabriel de la Torre; Pedro Hernández-Cruz; Ruth Martínez-Cruz; Eduardo Pérez-Campos
Journal:  Indian J Ophthalmol       Date:  2007 Sep-Oct       Impact factor: 1.848

Review 8.  Pterygium-The Good, the Bad, and the Ugly.

Authors:  Sara I Van Acker; Bert Van den Bogerd; Michel Haagdorens; Vasiliki Siozopoulou; Sorcha Ní Dhubhghaill; Isabel Pintelon; Carina Koppen
Journal:  Cells       Date:  2021-06-22       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.